Axsome Therapeutics
AXSM
AXSM
109 hedge funds and large institutions have $476M invested in Axsome Therapeutics in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
68% more funds holding
Funds holding: 65 → 109 (+44)
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
10.58% more ownership
Funds ownership: 44.53% → 55.11% (+11%)
Holders
109
Holding in Top 10
6
Calls
$28.5M
Puts
$10.9M
Top Buyers
| 1 | +$31.5M | |
| 2 | +$19.9M | |
| 3 | +$16.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.9M |
| 5 |
VMI
VHCP Management III
New York
|
+$14M |
Top Sellers
| 1 | -$50.3M | |
| 2 | -$11M | |
| 3 | -$9.64M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.26M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$5.3M |